Laroche Freres launches Azenda in the U.S.
A natural daily supplement from Europe that is redefining the concept of anti-aging.
12/08/05 Laroche Freres has announced the launch of Azenda, a natural daily supplement from Europe that is redefining the concept of anti-aging. Because of its many diverse benefits, Azenda is considered one of the most important and versatile dietary supplements available.
Until now, anti-aging has focused on exterior appearance, available in topical creams, gels, and quick fixes. But aging is more than a surface problem -- it affects both mind and body, most often through a loss of optimism and a deterioration of joint health. Azenda works from the inside to restore the mindset and mobility of youth. Backed by over one hundred clinical studies, Azenda has been scientifically proven to repair and rebuild cartilage, relieve joint discomfort, and restore a youthful, optimistic attitude.
Azenda's active ingredient (SAM-e), although well-known in Europe, is known only among a small U.S. audience as a highly effective natural antidepressant because of its ability to accelerate production of serotonin, the body's most important mood regulator. Recent clinical studies have proven that this natural substance has many more anti-aging benefits than previously known. Azenda's active ingredient is essential for the production of glutathione, the body's most powerful antioxidant. Glutathione is known as the "age buster" due to its critical role in ridding the body of free radicals and preventing oxidation -- the primary causes of premature aging. In addition, SAM-e is the only known substance that can actually help rebuild and repair damaged cartilage, a condition that affects 80% of people over 50.
Laroche Freres is committed to bringing to market premium brand neutriceutical using only the highest quality natural ingredients, with a continued focus on products that are effective, uplifting, and healing - products that help transform lives and move people in the direction of their dreams.
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-11-2005/0004087010&EDATE=
